In the aftermath of the COVID-19 pandemic, critics far and wide have spoken out against the influence pharmaceutical companies have had on American policy, particularly at the federal level.
This week, Republican presidential nominee Donald Trump addressed the issue during a podcast appearance, introducing his plan to rein in Big
Continue reading

Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!